Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT07015528
EARLY_PHASE1
Assessment of Drug Liking In Peri-procedural Clinical Settings
Sponsor: Stanford University
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-09-30
Completion Date
2027-07-31
Last Updated
2025-12-18
Healthy Volunteers
No
Conditions
Interventions
DRUG
Droperidol
Medication administered as a single intravenous dose.
DRUG
Placebo
Matching Placebo given by single intravenous (IV) administration.
Locations (1)
Stanford Hospital
Palo Alto, California, United States